PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15075350-4	2004	Pargyline and semicarbazide, specific inhibitors of MAO and SSAO, respectively, canceled this negative effect of MAO substrates on NOS2 expression.	Pargyline	0-9	amine oxidase, copper containing 3	Rattus norvegicus	60-64	
18539478-5	2008	However, combined treatment of this lower dose of S with pargyline inhibited SSAO, MAO, energy intake, weight gain and fat deposition.	Pargyline	57-66	amine oxidase, copper containing 3	Rattus norvegicus	77-81	
17977742-7	2007	P+S treatments abolished MAO and SSAO activities in any tested tissue.	Pargyline	0-3	amine oxidase, copper containing 3	Rattus norvegicus	33-37	
17977742-11	2007	Although our results did not directly demonstrate that amines are able to spontaneously produce in vivo the insulin-like effects described in vitro, we propose that P+S-induced reduction of fat deposition results from decreased food intake and from impaired MAO- and SSAO-dependent lipogenic and antilipolytic actions of endogenous or alimentary amines.	Pargyline	165-168	amine oxidase, copper containing 3	Rattus norvegicus	267-271	
1631902-3	1992	Inhibitor studies using the specific SSAO inhibitor semicarbazide and the monoamine oxidase inhibitor pargyline indicate that SSAO is responsible for metabolism of methylamine to formaldehyde.	Pargyline	102-111	amine oxidase, copper containing 3	Rattus norvegicus	126-130